Literature DB >> 28920166

Clinical significance of Aspergillus species isolated from respiratory specimens in patients with Mycobacterium avium complex lung disease.

K Furuuchi1, A Ito2, T Hashimoto2, S Kumagai3, T Ishida2.   

Abstract

Chronic pulmonary aspergillosis (CPA) is associated with mortality in patients with Mycobacterium avium complex lung disease (MAC-LD). An Aspergillus-positive respiratory specimen often reflects colonization, and thus the clinical significance of Aspergillus isolation in MAC-LD patients is not well understood. The objective of this study was to investigate the clinical characteristics and outcomes of MAC-LD patients in whom Aspergillus was isolated from respiratory specimens. We performed a retrospective review of the medical records of 329 MAC-LD patients. We compared the characteristics and mortality rates between patients with Aspergillus isolation and those without. All Aspergillus species detected from respiratory specimens within the follow-up period were reviewed. Aspergillus was detected in 40 (12.2%) of the 329 patients. There were no significant differences in the clinical characteristics and mortality rates between patients with and without Aspergillus isolation. Among the 40 patients with Aspergillus isolation, 9 (22.5%) developed CPA. CPA was most often caused by A. fumigatus. In the 40 Aspergillus-positive patients, patients with A. fumigatus isolation had a significantly higher mortality rate than those without (P < 0.001). The multivariate Cox proportional hazards model showed older age (P = 0.050), presence of respiratory comorbidities (P = 0.008), hypoalbuminemia (P < 0.001), and isolation of A. fumigatus (P = 0.005) to be prognostic factors for mortality in MAC-LD patients. There was no significant difference in the mortality rates between patients with Aspergillus isolation and those without. However, isolation of A. fumigatus may be associated with poor prognosis in MAC-LD patients.

Entities:  

Keywords:  Aspergillosis; Aspergillus species; Mycobacterium avium complex; Prognosis

Mesh:

Year:  2017        PMID: 28920166     DOI: 10.1007/s10096-017-3105-6

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  27 in total

1.  Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors.

Authors:  J Angrill; C Agustí; R de Celis; A Rañó; J Gonzalez; T Solé; A Xaubet; R Rodriguez-Roisin; A Torres
Journal:  Thorax       Date:  2002-01       Impact factor: 9.139

2.  Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems.

Authors:  D Rebecca Prevots; Pamela A Shaw; Daniel Strickland; Lisa A Jackson; Marsha A Raebel; Mary Ann Blosky; Ruben Montes de Oca; Yvonne R Shea; Amy E Seitz; Steven M Holland; Kenneth N Olivier
Journal:  Am J Respir Crit Care Med       Date:  2010-06-10       Impact factor: 21.405

3.  Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries.

Authors:  Jennifer Adjemian; Kenneth N Olivier; Amy E Seitz; Steven M Holland; D Rebecca Prevots
Journal:  Am J Respir Crit Care Med       Date:  2012-02-03       Impact factor: 21.405

Review 4.  Innate immunity to Aspergillus species.

Authors:  Stacy J Park; Borna Mehrad
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

5.  Isolation of Aspergillus in critically ill patients: a potential marker of poor outcome.

Authors:  Faisal Khasawneh; Tamam Mohamad; Mahmoud K Moughrabieh; Zongshan Lai; Joel Ager; Ayman O Soubani
Journal:  J Crit Care       Date:  2006-12       Impact factor: 3.425

6.  Chronic necrotizing pulmonary aspergillosis as a complication of pulmonary Mycobacterium avium complex disease.

Authors:  Yoshihiro Kobashi; Minoru Fukuda; Kouichiro Yoshida; Naoyuki Miyashita; Yoshihito Niki; Mikio Oka
Journal:  Respirology       Date:  2006-11       Impact factor: 6.424

7.  Microbial colonization and lung function in adolescents with cystic fibrosis.

Authors:  Andreas Hector; Tobias Kirn; Anjali Ralhan; Ute Graepler-Mainka; Sina Berenbrinker; Joachim Riethmueller; Michael Hogardt; Marlies Wagner; Andreas Pfleger; Ingo Autenrieth; Matthias Kappler; Matthias Griese; Ernst Eber; Peter Martus; Dominik Hartl
Journal:  J Cyst Fibros       Date:  2016-02-05       Impact factor: 5.482

Review 8.  Pathogenesis of Aspergillus fumigatus in Invasive Aspergillosis.

Authors:  Taylor R T Dagenais; Nancy P Keller
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

9.  [The clinical significance of Aspergillus isolation from airway samples in critically ill patients].

Authors:  Yan Shi; Hong-zhong Liu; Xiao-ting Wang; Ye Liu; Xi Rui; Bo Tang; Wen-zhao Chai; Hua Zhao
Journal:  Zhonghua Jie He He Hu Xi Za Zhi       Date:  2009-06

10.  The risk factors for developing of chronic pulmonary aspergillosis in nontuberculous mycobacteria patients and clinical characteristics and outcomes in chronic pulmonary aspergillosis patients coinfected with nontuberculous mycobacteria.

Authors:  Kazuaki Takeda; Yoshifumi Imamura; Takahiro Takazono; Masataka Yoshida; Shotaro Ide; Katsuji Hirano; Masato Tashiro; Tomomi Saijo; Kosuke Kosai; Yoshitomo Morinaga; Shigeki Nakamura; Shintaro Kurihara; Misuzu Tsukamoto; Taiga Miyazaki; Takayoshi Tashiro; Shigeru Kohno; Katsunori Yanagihara; Koichi Izumikawa
Journal:  Med Mycol       Date:  2015-11-03       Impact factor: 4.076

View more
  3 in total

1.  Concomitant Presence of Aspergillus Species and Mycobacterium Species in the Respiratory Tract of Patients: Underestimated Co-occurrence?

Authors:  Sarah Dellière; Cécile Angebault; Vincent Fihman; Françoise Foulet; Raphaël Lepeule; Bernard Maitre; Frédéric Schlemmer; Françoise Botterel
Journal:  Front Microbiol       Date:  2020-01-10       Impact factor: 5.640

Review 2.  Chronic Pulmonary Aspergillosis Following Nontuberculous Mycobacterial Infections: An Emerging Disease.

Authors:  Pakpoom Phoompoung; Methee Chayakulkeeree
Journal:  J Fungi (Basel)       Date:  2020-12-08

3.  Clinical Features and Treatment Outcomes of Pulmonary Mycobacterium avium-intracellulare Complex With and Without Coinfections.

Authors:  Grace Wang; Jack T Stapleton; Arthur W Baker; Nadine Rouphael; C Buddy Creech; Hana M El Sahly; Jason E Stout; Lisa Jackson; Edward Charbek; Francisco J Leyva; Kay M Tomashek; Melinda Tibbals; Aaron Miller; Sharon Frey; Samson Niemotka; Timothy L Wiemken; Nour Beydoun; Ghina Alaaeddine; Nicholas Turner; Emmanuel B Walter; Robin Chamberland; Getahun Abate
Journal:  Open Forum Infect Dis       Date:  2022-07-26       Impact factor: 4.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.